Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Synaptogenix (SNPX)
NASDAQ:SNPX
Holding SNPX?
Track your performance easily
SNPX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.32 - $7.21
Previous CloseN/A
Volume20.55K
Average Volume (3M)24.72K
Market Cap
$4.69M
Enterprise ValueN/A
Total Cash (Recent Filing)$17.38M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.85
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.45
Shares Outstanding1,355,613
10 Day Avg. Volume17,644
30 Day Avg. Volume24,723
Standard Deviation0.24
R-Squared0.06
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Synaptogenix News
PremiumCompany Announcements
Synaptogenix Restructures Leadership Amid Strategic Refocus
PremiumCompany Announcements
Synaptogenix CEO Dr. Tuchman’s Tenure Extended Through 2024Ownership Overview
9.39%
Insiders
0.76% Mutual Funds
<0.01% Other Institutional Investors
89.65% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SNPX FAQ
What was Synaptogenix’s price range in the past 12 months?
Synaptogenix lowest stock price was $2.32 and its highest was $7.21 in the past 12 months.
What is Synaptogenix’s market cap?
Synaptogenix’s market cap is $4.69M.
When is Synaptogenix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Synaptogenix’s earnings last quarter?
Currently, no data Available
Is Synaptogenix overvalued?
According to Wall Street analysts Synaptogenix’s price is currently Overvalued.
Does Synaptogenix pay dividends?
Synaptogenix does not currently pay dividends.
What is Synaptogenix’s EPS estimate?
Synaptogenix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Synaptogenix have?
Synaptogenix has 1,355,613 shares outstanding.
What happened to Synaptogenix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Synaptogenix?
Currently, no hedge funds are holding shares in SNPX
---
Company Description
Synaptogenix
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
---
SNPX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
ACADIA Pharmaceuticals
―
Biogen
―
Corcept Therapeutics
―
Axsome Therapeutics
―
Annovis Bio
―
Best Analysts Covering SNPX
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-18.00%
upgraded a buy rating 7 months ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -18.00% per trade.
---